Rhelixa
A leading company in epigenome analysis.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD19—28m (Dealroom.co estimates Aug 2024.)
Tokyo Japan (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
N/A | JPY3.0m | Early VC | |
N/A | JPY1.0m | Seed | |
N/A | N/A | Seed | |
N/A | JPY10.0m | Seed | |
N/A | Early VC | ||
$2.2m | Early VC | ||
* | JPY392m | Series B | |
* | JPY98.0m | Debt | |
Total Funding | AUD8.3m |
Related Content
Recent News about Rhelixa
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.